OMX30 1 631 -0,7%  OMXH25 4 011 -1,2%  OMXC20 1 002 -1,3%  Dow 21 410 0,1%  Nas 5 778 -0,4%  EUR 9,7609 0,1%  USD 8,6436 -0,9%  Olja 46,3 0,9%  Guld 1 251 0,5% 

Edwards Lifesciences Aktie

117,75USD -0,54USD -0,46%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Edwards Lifesciences Chart - 1 År - BTT

Fundamentala nyckeltal för Edwards Lifesciences

2016 2017e 2018e 2019e 2020e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 32,30 32,51 28,79 25,63 23,02
Resultat/aktie 2,89 3,54 3,99 4,49 5,00

Nyheter om Edwards Lifesciences Corp.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Edwards Lifesciences Corp.

ytterligare analyser

Edwards Lifesciences Peer Group

Edwards Lifesciences 117,75
-0,5%
pagehit

Lägg till instrument

Vad tycker du?

Profil Edwards Lifesciences Corp.till bolagsprofilen

Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Critical Care portfolio products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Realtidskurs Edwards Lifesciences Corp.

Bid
117,38
USD
Ask
118,23
USD
Kurstid
15:47
Börsen BTT

Aktiekurs Edwards Lifesciences Corp. i USDPUSH CHART

Kurs 117,75 USD -0,54 -0,46 %
Kurstid 15:47:16
Datum 27.06.2017
Öppning 118,04
Gårdagen 118,29
Dagshögsta 118,18
Dagslägsta 117,44
52 v. högsta 121,74
52 v. lägsta 81,12
52 v. perf.
Volym (Antal) 1 139
Börsvärde (SEK) 219,01 Mrd
Börsen
Kurs för 117,75 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 017,78 SEK.

Till aktien Edwards Lifesciences

Ticker
ISIN US28176E1082
Index S&P 500

Edwards Lifesciences Nyckeltal

Börsvärde i SEK 219,01 Mrd
Free float % 99,20
Antal aktier mio. 209,80
Cashflow/aktie i lokal valuta 3,18
Bokvärde/aktie i lokal valuta 12,57
60 dagar vola 28,42
PBV 7,43

Edwards Lifesciences Historiska kurser

2017-06-26 118,29 46 066
2017-06-23 120,14 103 023
2017-06-22 118,54 42 061
2017-06-21 118,91 61 145
2017-06-20 117,88 91 526